Catalyst Wire Dossier Catalyst Wire Dossier

Adecatumumab

adecatumumab · Amgen Research (Munich) GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adecatumumab, covering 2011-11-11 to 2011-11-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases [Phase 2]

See pricing